214 related articles for article (PubMed ID: 1650830)
21. Daily mirfentanil induces (cross-) tolerance to the rate-decreasing effects of morphine and not mirfentanil.
Gauthier CA; Bagley JR; Brockunier LL; France CP
Behav Pharmacol; 1999 Sep; 10(5):543-7. PubMed ID: 10780260
[TBL] [Abstract][Full Text] [Related]
22. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
[TBL] [Abstract][Full Text] [Related]
23. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
24. The rate-decreasing effects of fentanyl derivatives in pigeons before, during and after chronic morphine treatment.
Gauthier CA; Gerak LR; Bagley JR; Brockunier LL; France CP
Psychopharmacology (Berl); 1998 May; 137(1):67-73. PubMed ID: 9631958
[TBL] [Abstract][Full Text] [Related]
25. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
Adams JU; Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
[TBL] [Abstract][Full Text] [Related]
26. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
[TBL] [Abstract][Full Text] [Related]
27. Analgesic effects of phencyclidine-like drugs in rhesus monkeys.
France CP; Snyder AM; Woods JH
J Pharmacol Exp Ther; 1989 Jul; 250(1):197-201. PubMed ID: 2501476
[TBL] [Abstract][Full Text] [Related]
28. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
Comer SD; Burke TF; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
[TBL] [Abstract][Full Text] [Related]
29. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
Walker EA; Picker MJ; Granger A; Dykstra LA
J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
[TBL] [Abstract][Full Text] [Related]
30. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
Zernig G; Butelman ER; Lewis JW; Walker EA; Woods JH
J Pharmacol Exp Ther; 1994 Apr; 269(1):57-65. PubMed ID: 8169852
[TBL] [Abstract][Full Text] [Related]
31. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
[TBL] [Abstract][Full Text] [Related]
32. Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
France CP; Woods JH
J Pharmacol Exp Ther; 1988 Feb; 244(2):599-605. PubMed ID: 3346837
[TBL] [Abstract][Full Text] [Related]
33. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
Picker MJ; Cook CD
Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
[TBL] [Abstract][Full Text] [Related]
34. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
35. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
Butelman ER; France CP; Woods JH
J Pharmacol Exp Ther; 1993 Jan; 264(1):145-51. PubMed ID: 8093721
[TBL] [Abstract][Full Text] [Related]
36. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function.
Gengo PJ; Pettit HO; O'Neill SJ; Su YF; McNutt R; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1227-33. PubMed ID: 14534367
[TBL] [Abstract][Full Text] [Related]
37. Meptazinol: a novel Mu-1 selective opioid analgesic.
Spiegel K; Pasternak GW
J Pharmacol Exp Ther; 1984 Feb; 228(2):414-9. PubMed ID: 6141283
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
Picker M; Dykstra LA
J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
[TBL] [Abstract][Full Text] [Related]
39. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
Walker EA; Makhay MM; House JD; Young AM
J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
[TBL] [Abstract][Full Text] [Related]
40. Discriminative stimulus effects of nalbuphine in rhesus monkeys.
Gerak LR; France CP
J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
